A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2011
11/15/2011	US8058426 Phosphorus-containing compounds and uses thereof
11/15/2011	US8058344 Glycodendrimers having biological activity
11/15/2011	US8058314 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
11/15/2011	US8058289 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
11/15/2011	US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011	US8058238 High purity lipopeptides
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8058025 Methods for determining efficacy of chemotherapeutic agents
11/15/2011	US8058012 Five-helix protein
11/15/2011	US8057806 Viruses comprising mutant ion channel protein
11/15/2011	US8057803 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/15/2011	US8057801 Tick galectin
11/15/2011	US8057790 Treatment of malodour
11/15/2011	US8057162 vaccination directed against the hepatitis C virus (HCV);
11/15/2011	CA2685440C Process for producing benzoxazine derivative and production intermediate thereof
11/15/2011	CA2479126C Combination treatments for chemokine-mediated diseases
11/15/2011	CA2477212C Novel arylamidine derivative or salt thereof
11/15/2011	CA2449403C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/15/2011	CA2399480C Haemophilus influenza outer membrane protein and use thereof in vaccination
11/15/2011	CA2392877C Improvements in or relating to immune responses to hiv
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/10/2011	WO2011140550A2 Immunogen adherence and method of making and using same
11/10/2011	WO2011140519A2 In vivo gelling pharmaceutical pre-formulation
11/10/2011	WO2011140310A2 Povidone-iodine topical composition
11/10/2011	WO2011140296A1 Triazoles as inhibitors of fatty acid synthase
11/10/2011	WO2011140255A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	WO2011140232A2 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	WO2011140128A2 Nail discoloration and fungus treatment
11/10/2011	WO2011140126A2 Nail discoloration and fungus treatment
11/10/2011	WO2011140009A1 Methods of using semi-synthetic glycopeptides as antibacterial agents
11/10/2011	WO2011139881A2 Compositions containing purine and pyrimidine nucleosides, peptides, and manganese and their uses
11/10/2011	WO2011139832A2 Method for treating mycobacterial infections
11/10/2011	WO2011139791A2 Bisphosphonamidate prodrugs and uses thereof
11/10/2011	WO2011139709A2 Methods of treating retroviral infections and related dosage regimes
11/10/2011	WO2011139513A1 Compounds for the treatment of hepatitis c
11/10/2011	WO2011139385A2 Genetic signatures in hiv-1 subtype c envelope glycoproteins
11/10/2011	WO2011139348A2 Uses of phospholipid conjugates of synthetic tlr7 agonists
11/10/2011	WO2011139226A1 Compounds, medicaments and methods of treatment for helicobacter pylori infection.
11/10/2011	WO2011138666A1 Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof
11/10/2011	WO2011138489A1 Use of casein hydrolysates as antiviral agents
11/10/2011	WO2011138484A1 Aqueous pharmaceutical system for the administration of drugs to the nails
11/10/2011	WO2011137758A1 Novel ketolide derivatives, preparation methods and pharmaceutical compositions thereof
11/10/2011	WO2011137571A1 Human-derived neutralizing antibody rvfab5 against rabies virus glycoprotein
11/10/2011	WO2011137570A1 Human-derived neutralizing antibody rvfab8 against rabies virus glycoprotein
11/10/2011	WO2011137569A1 Humanized neutralizing antibody rvfab3 against rabies virus glycoprotein
11/10/2011	WO2011137503A1 Methods for preparing ruthenium phosphine complexes with a structure containing picolinate and/or diimine and/or biphosphine ions, ruthenium phosphine complexes obtained by these methods and uses thereof
11/10/2011	WO2011092655A3 Mentha suaveolens essential oil and therapeutic activities thereof
11/10/2011	WO2011090712A3 Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
11/10/2011	WO2011088401A3 Development of a high-throughput screen for the identification of novel antifungal drug candidates
11/10/2011	WO2011088126A3 Treatment of viral infection with prenyltransferase inhibitors
11/10/2011	WO2011084967A3 Methods and compositions for providing protective immunity in the elderly
11/10/2011	WO2011076873A9 Influenza targets
11/10/2011	WO2011076784A3 New inhibitors of cyclophilins and uses thereof
11/10/2011	WO2011072287A3 Method for late introduction of the (8r)-hydroxyl group in carbapenem beta-lactam antibiotic synthesis
11/10/2011	WO2010116048A8 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
11/10/2011	WO2008062206A8 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus
11/10/2011	US20110275698 "test and treat" strategy for treating transforming hpv infection
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011	US20110275661 Tricyclic nitrogen compounds used as antibacterials
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275654 Long term treatment of hiv-infection with tmc278
11/10/2011	US20110275652 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	US20110275635 Small molecule inhibitors of nads, namnat, and nmnat
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
11/10/2011	US20110275621 Hiv integrase inhibitors
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275603 Novel immunomodulator and anti-inflammatory compounds
11/10/2011	US20110275602 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
11/10/2011	US20110275589 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
11/10/2011	US20110275587 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
11/10/2011	US20110275586 Antibacterial aminoglycoside analogs
11/10/2011	US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids
11/10/2011	US20110274770 Antiseptic compositions and methods
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274755 Supportive treatment of liver disease
11/10/2011	US20110274746 Therapeutic Liposomes and Methods For Producing and Using the Same
11/10/2011	US20110274743 Medicament for the Treatment of Pain and Inflammation
11/10/2011	US20110274730 Biosurfactant composition produced by a new bacillus licheniforms strain, uses and products thereof
11/10/2011	US20110274726 Chitosan foam medical devices and methods
11/10/2011	US20110274725 Decomposable biocompatible hydrogels and system and method for using same
11/10/2011	US20110274722 Food containing a probiotic and an isolated beta-glucan and methods of use thereof
11/10/2011	US20110274721 Hiv vaccines based on env of multiple clades of hiv
11/10/2011	US20110274720 Capsular gram-positive bacteria bioconjugate vaccines
11/10/2011	US20110274719 Helicobacter system and uses thereof
11/10/2011	US20110274717 POLYSACCHARIDE CONJUGATION WITH DETOXIFIED E. coli HEAT LABILE ENTEROTOXIN (LT) USED AS VACCINE
11/10/2011	US20110274714 Broad Spectrum Vaccine Against Non-Typhoidal Salmonella
11/10/2011	US20110274712 Antigenic compositions
11/10/2011	US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof
11/10/2011	US20110274701 Composition and method for preventing/decreasing respiratory illness
11/10/2011	US20110274700 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274696 Antibodies to ccr2

1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 1798